$Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years$

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years

Ziad Farah, Sabreen Ali, Fiona Price-Kuehne, Charles G Mackworth-Young Department of Rheumatology, Charing Cross Hospital, London, UKObjectives: To evaluate the long-term efficacy and safety of tocilizumab (TCZ) in clinical patients with rheumatoid arthritis (RA) refractory to synthetic disease-modi...

Full description

Bibliographic Details
Main Authors:	Farah Z, Ali S, Price-Kuehne F, Mackworth-Young CG
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-03-01
Series:	Biologics: Targets & Therapy
Subjects:	tocilizumab rheumatoid arthritis refractory rheumatoid long term efficacy safety tolerability
Online Access:	https://www.dovepress.com/tocilizumab-in-refractory-rheumatoid-arthritis-long-term-efficacy-safe-peer-reviewed-article-BTT

Similar Items

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

PREDICTION OF TOCILIZUMAB AND RITUXIMAB EFFECTIVENESS IN RHEUMATOID ARTHRITIS
by: Volkava M. V.
Published: (2019-11-01)

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
by: Han Joo Baek, et al.
Published: (2019-07-01)

Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study
by: Suhel Gabriele Al Khayyat, et al.
Published: (2022-11-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
by: Rossella Talotta, et al.
Published: (2018-06-01)

TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: T V Popkova, et al.
Published: (2012-05-01)

Exploring the Role of Interleukin-6 Receptor Inhibitor Tocilizumab in Patients with Active Rheumatoid Arthritis and Periodontal Disease
by: Codrina Ancuța, et al.
Published: (2021-02-01)

Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
by: Dimitrios A. Pappas, et al.
Published: (2019-06-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
by: Bambang Setyohadi, et al.
Published: (2018-06-01)

Intravenous pamidronate for refractory rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2012-01-01)

FUNCTIONAL ABILITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOCILIZUMAB THERAPY
by: Anna Sergeyevna Starkova, et al.
Published: (2014-02-01)

Tocilizumab in rheumatoid arthritis‐associated peripheral ulcerative keratitis: A 1‐year follow‐up case report
by: Jia Huang, et al.
Published: (2022-03-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
by: Laetitia Diep, et al.
Published: (2022-10-01)

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)
by: E L Nasonov, et al.
Published: (2010-04-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-11-01)

Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies
by: Amal Saki, et al.
Published: (2021-07-01)

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
by: Jean Darloy, et al.
Published: (2019-01-01)

Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis
by: Siyuan Fan, et al.
Published: (2023-06-01)

Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
by: Suzuki T, et al.
Published: (2018-03-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Sivakami Janahiraman, et al.
Published: (2022-07-01)

Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature
by: Hiroki Wakabayashi, et al.
Published: (2019-04-01)

Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study
by: Areej S. Albahdal, et al.
Published: (2024-02-01)

Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies
by: Boulos Haraoui, et al.
Published: (2019-03-01)

Use of tocilizumab in the combination treatment of a COVID-19 patient with concomitant rheumatoid arthritis (a case report)
by: V. A. Vizir, et al.
Published: (2021-10-01)

EVALUATION OF THE EFFICIENCY OF TOCILIZUMAB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS BY ULTRASOUND AND X-RAY DATA
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-02-01)

The Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Receiving Tocilizumab: A Systematic Review and Meta-Analysis
by: Ping-Hung Ko, et al.
Published: (2024-01-01)

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
by: Sara Gale, et al.
Published: (2019-02-01)

The efficacy and safety of short-term and low-dose IL-2 combined with tocilizumab to treat rheumatoid arthritis
by: Sheng-Xiao Zhang, et al.
Published: (2024-04-01)

RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
by: Alisson Pugliesi, et al.
Published: (2023-07-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

Short-Term Efficacy and Safety of Subcutaneous Tocilizumab in Rheumatoid Arthritis Patients in Pakistan: A Real-World Experience
by: Tashia Malik, et al.
Published: (2023-06-01)

ANEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: D A Belenky, et al.
Published: (2012-05-01)

Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study
by: Daniela Greco, et al.
Published: (2020-07-01)

Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
by: Katie Tuckwell, et al.
Published: (2019-12-01)

Safe and Efficient Use of Tocilizumab in Rheumatoid Arthritis Patient on Maintenance Hemodialysis: A Case Report
by: Paula Kilić, et al.
Published: (2023-08-01)